Thermo Fisher Scientific Inc. has expanded its strategic partnership with Sanofi to enable additional U.S. drug product ...

Champions Oncology has appointed Rob Brainin as Chief Executive Officer and member of the Board of Directors, effective ...

GenesisM has broken ground on its 154,000-square-foot Class A biomanufacturing facility at 45 Crosby Drive in Bedford, ...

Samsung Bioepis has entered into a license, development and commercialization agreement with Harrow for its ophthalmology ...

Current CEO Didier Dargent will transition to Executive Chairman.

PCI Pharma Services has received a strategic investment co-led by Bain Capital and existing lead investor Kohlberg, and ...

LogiCare3PL, a division of BioCare Inc., has partnered with ChiRhoClin Inc., a leader in pancreatic and gastrointestinal ...

Tobin Scientific, a provider of cGMP-compliant warehousing and transportation solutions, has opened its newest cGMP warehouse ...

RZL-012 is an injectable treatment for focal fat reduction that is currently progressing toward Phase 3 trials.

The U.S. FDA has accepted a Biologics License Application (BLA) for BAT2506, a proposed biosimilar to Simponi (golimumab).

Farwell succeeds Jordan Dubow, who will continue to serve as a consultant and chair of the Clinical Advisory Board.

The U.S. FDA has approved a prefilled syringe presentation of GSK plc’s SHINGRIX for the prevention of shingles.